Seelos Therapeutics Correlations

SEEL Stock

USD 0.39 0.11 22.00%

The current 90-days correlation between Seelos Therapeutics and Better Therapeutics is -0.07 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Seelos Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Seelos Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Seelos Therapeutics Correlation With Market

Good diversification

The correlation between Seelos Therapeutics and DJI is -0.13 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Seelos Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Seelos Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Seelos Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Seelos Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Seelos Therapeutics to buy it.

Moving together with Seelos OTC Stock

0.88	PPERY	Bank Mandiri Persero	Pair Corr
0.85	PPERF	Bank Mandiri Persero	Pair Corr
0.76	BKRKF	PT Bank Rakyat	Pair Corr
0.88	BKRKY	Bank Rakyat	Pair Corr
0.65	PBCRY	Bank Central Asia	Pair Corr
0.82	PTBRY	Bank Negara Indonesia Normal Trading	Pair Corr
0.68	SHG	Shinhan Financial	Pair Corr
0.92	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.89	KO	Coca Cola Fiscal Year End 11th of February 2025	Pair Corr
0.86	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr

Moving against Seelos OTC Stock

0.88	CSCO	Cisco Systems	Pair Corr
0.87	AXP	American Express Fiscal Year End 24th of January 2025	Pair Corr
0.86	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.83	DIS	Walt Disney Sell-off Trend	Pair Corr
0.83	T	ATT Inc Sell-off Trend	Pair Corr
0.69	HD	Home Depot	Pair Corr
0.59	INTC	Intel Sell-off Trend	Pair Corr
0.57	HPQ	HP Inc	Pair Corr
0.36	KB	KB Financial Group	Pair Corr
0.36	XOM	Exxon Mobil Corp Fiscal Year End 7th of February 2025	Pair Corr

Related Correlations Analysis

	ATAI	MNMD	GHRS	FRLN	CYBN	AWKNF	PULM	CAPR	AKTX	DFFN
ATAI		0.82	0.74	0.21	0.41	0.39	0.89	0.09	-0.77	-0.79	ATAI
MNMD	0.82		0.79	-0.04	0.59	0.56	0.65	0.26	-0.7	-0.73	MNMD
GHRS	0.74	0.79		-0.03	0.42	0.64	0.61	0.13	-0.61	-0.63	GHRS
FRLN	0.21	-0.04	-0.03		-0.62	-0.28	0.16	-0.79	0.14	0.09	FRLN
CYBN	0.41	0.59	0.42	-0.62		0.33	0.37	0.72	-0.66	-0.55	CYBN
AWKNF	0.39	0.56	0.64	-0.28	0.33		0.29	0.37	-0.36	-0.43	AWKNF
PULM	0.89	0.65	0.61	0.16	0.37	0.29		0.2	-0.84	-0.84	PULM
CAPR	0.09	0.26	0.13	-0.79	0.72	0.37	0.2		-0.52	-0.39	CAPR
AKTX	-0.77	-0.7	-0.61	0.14	-0.66	-0.36	-0.84	-0.52		0.88	AKTX
DFFN	-0.79	-0.73	-0.63	0.09	-0.55	-0.43	-0.84	-0.39	0.88		DFFN
	ATAI	MNMD	GHRS	FRLN	CYBN	AWKNF	PULM	CAPR	AKTX	DFFN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PULM	+ 0.89	ATAI
DFFN	+ 0.88	AKTX
MNMD	+ 0.82	ATAI
GHRS	+ 0.79	MNMD
GHRS	+ 0.74	ATAI
CAPR	+ 0.72	CYBN

High negative correlations

DFFN	- 0.84	PULM
AKTX	- 0.84	PULM
CAPR	- 0.79	FRLN
DFFN	- 0.79	ATAI
AKTX	- 0.77	ATAI
DFFN	- 0.73	MNMD

Risk-Adjusted Indicators

There is a big difference between Seelos OTC Stock performing well and Seelos Therapeutics OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Seelos Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ATAI	4.01	0.14	0.08	0.17	3.88	(5.19)	11.01	(6.87)	25.61
MNMD	3.64	0.00	0.06	0.11	3.73	(4.82)	9.76	(7.51)	24.75
GHRS	3.25	0.06	0.01	0.18	3.86	(3.75)	8.59	(5.76)	26.09
FRLN	5.90	(0.01)	0.00	0.13	0.00	0.00	14.23	(13.11)	72.38
CYBN	3.66	0.46	0.10	0.92	3.87	(4.30)	9.30	(7.40)	24.94
AWKNF	7.38	0.91	0.04	(0.27)	8.61	(9.99)	18.18	(19.73)	55.67
PULM	5.87	2.29	0.44	(2.52)	3.70	(8.24)	16.69	(4.98)	92.85
CAPR	7.13	2.62	0.33	(2.83)	5.84	(9.08)	18.22	(10.45)	75.82
AKTX	5.00	(1.46)	0.00	3.53	0.00	0.00	10.10	(14.53)	47.27
DFFN	2.40	(0.55)	0.00	(1.42)	0.00	0.00	4.09	(5.32)	12.34

Be your own money manager

Our tools can tell you how much better you can do entering a position in Seelos Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Tickers Now

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites

All Next

Launch Module

Seelos Therapeutics Corporate Management

Elected by the shareholders, the Seelos Therapeutics' board of directors comprises two types of representatives: Seelos Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Seelos. The board's role is to monitor Seelos Therapeutics' management team and ensure that shareholders' interests are well served. Seelos Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Seelos Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Gopal Krishna	Head Operations	Profile
Michael Golembiewski	Chief Officer	Profile
Kimberly Farrand	Senior Operations	Profile
Raj JD	Chairman, Founder	Profile
Anthony Marciano	Chief Officer	Profile
Karen Fusaro	Senior Operations	Profile
Tim MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC